Eur Rev Med Pharmacol Sci 2020; 24 (9): 5178-5179

DOI: 10.26355/eurrev_202005_21214

Editorial – High dose intravenous immunoglobulins as a therapeutic option for COVID-19 patients

C. Scoppetta, G. Di Gennaro, F. Polverino

Department of Human Physiology and Pharmacology, “Sapienza” University of Rome, Rome, Italy. cscoppetta@tin.it


Free PDF Download

To cite this article

C. Scoppetta, G. Di Gennaro, F. Polverino
Editorial – High dose intravenous immunoglobulins as a therapeutic option for COVID-19 patients

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 9
Pages: 5178-5179
DOI: 10.26355/eurrev_202005_21214